Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Selective serotonin reuptake inhibitors and risk of cerebral bleeding.

Hankey GJ.

Stroke. 2014 Jul;45(7):1917-8. doi: 10.1161/STROKEAHA.114.005844. No abstract available.

2.

Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population.

Aarts N, Akoudad S, Noordam R, Hofman A, Ikram MA, Stricker BH, Visser LE, Vernooij MW.

Stroke. 2014 Jul;45(7):1951-7. doi: 10.1161/STROKEAHA.114.004990.

3.

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke.

Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, Broderick J, Woo D.

Stroke. 2007 Nov;38(11):3049-51.

4.

Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis.

Hackam DG, Mrkobrada M.

Neurology. 2012 Oct 30;79(18):1862-5. doi: 10.1212/WNL.0b013e318271f848. Review.

PMID:
23077009
5.

Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.

Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, García Rodríguez LA, Christensen K, Gaist D.

Stroke. 2002 Jun;33(6):1465-73.

6.

Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study.

Löppönen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, Hillbom M.

J Neurosurg. 2014 Jun;120(6):1358-63. doi: 10.3171/2013.12.JNS131898.

PMID:
24506245
7.

Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.

Ramasubbu R.

J Clin Psychiatry. 2004 Dec;65(12):1642-53. Review.

PMID:
15641869
8.
9.

Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality.

Mortensen JK, Larsson H, Johnsen SP, Andersen G.

Stroke. 2014 Jul;45(7):2121-3. doi: 10.1161/STROKEAHA.114.005302.

10.

Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Whitaker HJ, Farrington CP, Card TR, West J.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):175-81.

12.

Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR.

Maschino F, Hurault-Delarue C, Chebbane L, Fabry V, Montastruc JL, Bagheri H; French Association of Regional Pharmacovigilance Centers..

Eur J Clin Pharmacol. 2012 Nov;68(11):1557-60. doi: 10.1007/s00228-012-1268-8.

PMID:
22527341
13.

[Is the use of selective serotonin reuptake inhibitors associated with an increased risk of bleeding?].

Dall M, Hallas J.

Ugeskr Laeger. 2006 Jun 5;168(23):2232-6. Review. Danish.

PMID:
16768974
14.

Neonatal intraventricular haemorrhage associated with maternal use of paroxetine.

Duijvestijn YC, Kalmeijer MD, Passier AL, Dahlem P, Smiers F.

Br J Clin Pharmacol. 2003 Nov;56(5):581-2.

15.

Short-term use of selective serotonin reuptake inhibitors increases risk of gastrointestinal bleeding in men with psychiatric diagnoses.

Ayers K, Waljee AK, Saini SD.

Gastroenterology. 2014 Nov;147(5):1173-4. doi: 10.1053/j.gastro.2014.09.010. No abstract available.

PMID:
25240167
16.

Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks.

Turner MS, May DB, Arthur RR, Xiong GL.

J Intern Med. 2007 Mar;261(3):205-13. Review.

17.

Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.

Skop BP, Brown TM.

Psychosomatics. 1996 Jan-Feb;37(1):12-6. Review.

PMID:
8600488
18.

Selective serotonin reuptake inhibitors: infrequent medical adverse effects.

Goldberg RJ.

Arch Fam Med. 1998 Jan-Feb;7(1):78-84. Review.

PMID:
9443704
19.

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH.

Arch Intern Med. 2003 Jan 13;163(1):59-64.

PMID:
12523917
20.

Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.

Lee YC, Lin CH, Lin MS, Lu Y, Chang CH, Lin JW.

J Clin Psychiatry. 2016 Jan;77(1):e1-7. doi: 10.4088/JCP.14m09394.

PMID:
26845272
Items per page

Supplemental Content

Support Center